S phingosine 1-phosphate (S1P) analogue FTY720 was approved recently by the U.S. Food and Drug Administration as a first-line treatment for relapsing forms of multiple sclerosis (1) . It suppresses immune responses by blocking lymphocyte egress, but the underlying mechanism is not completely understood (2, 3) . Early studies suggested that binding of FTY720 to the S1P 1 receptor (S1P 1 R) caused internalization of the receptor in lymph node lymphocytes and thus prevented them from responding to a high concentration of S1P in the lymphatic sinus (4) (5) (6) (7) . This receptor internalization-dependent mechanism has been challenged by several investigations (8, 9) . Sinha et al. (8) reported that egress of B lymphocytes from lymph nodes was not solely dependent on S1P-mediated chemotaxis (8) . Also, pertussis toxin (PTX)-treated, S1P 1 R-deficient T cells could exit lymph nodes, albeit at a reduced frequency (9) . Moreover, in comparison with CCR7-positive T cells, CCR7-deficient T cells displayed a compromised response to FTY720-induced lymphopenia (9) . These investigations argue that a receptor internalization-independent mechanism, either alone or in conjunction with receptor internalization, is involved in FTY720-mediated blockade on lymphocyte egress. S1P 1 R is a G protein-coupled receptor and activates exclusively PTX-sensitive Gai/o proteins to propagate the entirety of its signal (10) . The primary PTX substrates in T lymphocytes are Gai2 and Gai3 as shown by in vitro PTX labeling and cDNA cloning (11, 12) . Our previous study has demonstrated that these two Gai proteins can be functionally overlapping, distinct, or antagonistic in chemotactic responses in a receptor-specific fashion (13, 14) . In the current study, we use Gai2-and Gai3-deficient T cells, in conjunction with intravital time-lapse imaging, to delineate potentially distinct activities of these two Gai proteins in the multistep process of T cell egress. We find that in marked contrast to wild-type (WT) and Gai3-deficient T cells, Gai2-deficient T cells cannot be sequestered sufficiently in lymphoid tissue by FTY720. The drug appeared to diminish interactions between T cells and the sinus in the presence of Gai2 and to promote them migrating away from an exit, causing lymphopenia. The study suggests for the first time, to our knowledge, involvement of T cell adhesion to the sinus for T cell egress.
Materials and Methods

Mice
Gai2
2/2 , Gai3 2/2 , and WT control mice on a mixed 129Sv/C57BL/6 background were generous gifts from Dr. Lutz Birnbaumer (National Institute of Environmental Health Sciences, Research Triangle Park, NC) (15) , and the mice were backcrossed with C57BL/6 mice six times as described (16) . Both female and male mice were used at 4-6 wk of age unless otherwise indicated. The mice were housed in specific pathogenfree cages at the animal facilities of the Massachusetts General Hospital in accordance with institutional guidelines. The study was reviewed and approved by the Massachusetts General Hospital Subcommittee on Research Animal Care.
In vivo flow cytometry T cells were isolated from lymph nodes of the indicated mice as described previously (17) , suspended in RPMI 1640 medium supplemented with 2% FBS, and stained with 10 mM DiD (Invitrogen) for 30 min in a humidified incubator at 37˚C followed by two washes with serum-free RPMI 1640. A total of 5 3 10 6 resultant cells per mouse were adoptively transferred into naive WT, Gai2 2/2 , or Gai3 2/2 mice via the tail vein. The recipients were anesthetized 16 h later by i.p. injection of a mixture of ketamine (80 mg/ kg) and xylazine (20 mg/kg). Fluorescently labeled donor cells were then counted by in vivo flow cytometry to establish control values before gavage of mice with either 1 mg/kg of FTY720 or 10 mg/kg of SEW2871 (Cayman Chemical). SEW2871 was administered every 12 h to maintain a sufficient level of the drug in the plasma (18) . Fluorescently labeled cells in circulation were counted by in vivo flow cytometer at the indicated time points under anesthesia. The mouse to be examined by in vivo flow cytometry was positioned on a custom-built inverted microscope stage equipped with a warming tube to keep body temperature constant as described (19) . A stationary laser beam was focused through cylindrical optics onto the ear blood vessel, forming a ∼5-mm-wide slit whose long axis was perpendicular to the vessel, and the length was adjusted to match its diameter. As individual fluorescently labeled cells passed through the excitation beam, a burst of fluorescence was generated with a lightemitting diode at a wavelength of 633 nm, collected by the microscope objective lens, and detected by a photomultiplier tube through a confocal slit aperture. Matlab software developed in-house was used to determine the number of peaks per unit time as well as peak height and pulse width.
Infection of Gai2
2/2 T cells with Gai2/3-expressing lentivirus
To generate a lentivirus expressing Gai2 or Gai3, Gai2 or Gai3 cDNA was subcloned into the multiple cloning site of a HIV-based lentiviral vector, pCDH1-copGFP (System Biosciences). The constructed and control GFP lentivirus were produced by transfection of the constructs individually into 293TN cells along with a ViralPower lentiviral packaging mix (System Biosciences). The culture supernatant was collected 48 h later, and viral titers were determined in 293TN cells based on the number of GFP + cells at the highest titration of the supernatant. For infection, T cells prepared from Gai2 2/2 mice were first stimulated with anti-CD3/anti-CD28 for 24 h to enhance their susceptibility to viral infection. Lentiviral culture supernatant was then added to the T cell culture at a virus to cell ratio of 20:1 to 50:1 overnight in the presence of 8 mg/ml polybrene followed by culturing these cells for an additional 48 h after replenishment of half of the medium. The percentage of GFP + cells was ∼35% on average as determined by flow cytometry. The infected cells were administered i.v. into cognate WT mice at 4 3 10 6 cells per mouse. GFP + cells were counted by in vivo flow cytometry before and after FTY720 treatment as above.
Intravital imaging and analysis of T cell egress
T cells isolated from WT, Gai2 2/2 , or Gai3 2/2 mice were stained with 20 mM CMTMR or 10 mM CFSE (both dyes from Invitrogen) for 20 min at 37˚C, respectively. The labeled cells were mixed at a 1:1 ratio of the two indicated cell types and adoptively transferred by i.v. tail injection of 1 3 10 7 cells per mouse. The recipient mice were treated by gavage with FTY720 (1 mg/kg) or saline 4 h later, followed by s.c. injection into a hind footpad of 15 mg anti-LYVE-1 Ab (R&D Systems) conjugated with Alexa Fluor 647 (mAb labeling kit; Invitrogen). The mouse was anesthetized after 16 h and placed on an electrically heated plate to maintain temperature at 36˚C. The popliteal lymph node was exposed by small skin incisions and bathed with a continuous flow of warm saline to maintain a local temperature at 36˚C during the imaging. Intravital imaging of the lymph node was performed by a home-built microscope, and images were acquired under the control of software developed in-house (19) . The in vivo confocal microscope was equipped with three photomultiplier tubes (R9110; Hamamatsu) that were optimized to provide bright images with a high contrast. Each xy-plane spanned 250 3 250 mm at a resolution of two pixels per micrometer. Stacks of images were acquired with a z-axis resolution of 3 mm per section, and time-series images were obtained at a 20-s interval. To determine whether a cell was inside, outside, or on the border of a cortical sinus, each cell located relative to the sinusoid wall was assessed in the xy-plane and/or z-plane. The moving distances and velocities of the tacking cells were tracked for each video segment and calculated using ImageJ software (NIH Image).
Statistical analysis
Statistical tests were performed using one-way ANOVA for multiple group comparisons. A p value ,0.05 was considered significant.
Results
T cells from Gai2
2/2 mice cannot be sequestered sufficiently by FTY720
To explore whether Gai2 and Gai3 played a distinct role in FTY720-induced lymphopenia, we tracked the circulation of adoptively transferred Gai2-and Gai3-deficient T cells in real time in a living animal after FTY720 treatment by an in vivo flow cytometer (20) . The instrumentation allows detection and quantification of adoptively transferred, fluorescently labeled cells flowing through the same ear vessel in live animals over an extended period of time without the extraction of blood samples because repeated blood draws potentially can cause stress and reduce the number of circulating lymphocytes (20) (21) (22) . To quantify circulating cells, T cells isolated from WT, Gai2 2/2 , or Gai3 2/2 mice were labeled with a vital red fluorescent dye before being administered to cognate WT mice and counted 16 h later via the ear vessel to establish control values (Fig. 1, time 0) . The donor cells were monitored in the same ear vessel at the indicated times after gavage of the mice with 1 mg/kg FTY720. As shown in Fig. 1A , the number of WT T cells declined precipitously over a 4-h period of time and reached the lowest level at 8 h after FTY720 treatment. Gai3 2/2 T cells also reached the lowest level at a similar time window, although they were refractory to leaving the circulation for the initial 4 h. The number of Gai2 2/2 T cells in circulation diminished similar to that of WT T cells in the first 4 h, but it never reached the lowest levels as those numbers seen with WT and Gai3 2/2 T cells. Rather, Gai2-deficient T cells circulated back to the blood, reached the initial level by 8 h, and remained at the level afterward. In sharp contrast, WT and Gai3 2/2 T cells were trapped in the tissues, returning to the blood slowly and gradually over a period of 3 d as described previously (23) . To rule out that a faster recovery of circulating Gai2 2/2 T cells after FTY720 treatment resulted from a release of the cells from nonlymphoid tissues such as the lung or liver, the number of circulating T cells was also monitored directly in the lymph. A similar reduction in the number of circulating T cells followed by a faster recovery again was observed in the lymph only in the absence of Gai2 (Supplemental Fig. 1A ).
Of note, numbers of circulating Gai2 2/2 , Gai3 2/2 , and WT T cells differed at the time of FTY720 administration as well as in saline control mice (Fig. 1A, Supplemental Fig. 1B) , even though the same number of cells were adoptively transferred into the mice. An increase in circulating Gai2 2/2 T cells but a decrease in Gai3 2/2 T cells relative to WT cells was constantly observed and hinted at a difference between Gai2 and Gai3 in the regulation of T cell trafficking. For a better comparison of FTY720-induced lymphopenia, the numbers of circulating T cells were normalized to 1 at time 0 in subsequent studies. After the normalization, a slight but significant increase in FTY720-induced sequestration of Gai3 2/2 T cells still was demonstrated when compared with that of WT T cells (data not shown).
To exclude the possibility that insufficient sequestration of Gai2 2/2 T cells resulted from overlapping stimulation of other S1P receptors by FTY720, the S1P 1 R-specific agonist SEW2871 was tested. Unlike FTY720, which can potentially activate other G proteins besides Gai2 or Gai3 by binding to additional S1P receptors such as S1P 4 R on T cells, SEW2871 induces lymphopenia via exclusive activation of S1P 1 R (24). Like FTY720, SEW2871 caused lymphopenia persistently in Gai3 2/2 and WT T cells but only transiently in Gai2 2/2 T cells (Fig. 1B) . The result suggests the involvement of S1P 1 R only in the action of FTY720 in Gai2 2/2 T cells. Similar results were also attained in reciprocal experiments in which WT, Gai2 2/2 , or Gai3
T cells were introduced into Gai2
mice (data not shown), with only Gai2 2/2 T cells remaining in the circulation after FTY720 administration. Clearly, a defect in T cells rather than endothelial cells ablated FTY720-induced lymphopenia in the absence of Gai2.
Moreover, an insufficient response of Gai2 2/2 T cells to FTY720 was also unlikely to be caused by altered T cell differentiation in the absence of Gai2 because previous studies showed normal T cell development in the animal (15, 25) . To further corroborate this, Gai2 expression was restored to a WT level in the cells by the infection of the cells with a GFP-lentivirus constructed with Gai2 or Gai3 or a control GFP-lentivirus as shown in Supplemental Fig. 1C . The infected cells were administered to cognate WT mice and counted before and after FTY720 treatment as above. Gai2 2/2 T cells responded to FTY720-mediated sequestration normally after infection with Gai2/GFP-lentivirus but not with Gai3/GFP-lentivirus or control GFP-lentivirus (Fig. 1D) . The ability of ectopic Gai2 expression to restore FTY720 responses in the cells unambiguously confirms that a loss of Gai2 in S1P 1 R-mediated signaling is directly responsible for the insufficient response of Gai2 2/2 T cells to FTY720.
Similar downregulation of S1P 1 R on T cells in the presence or absence of Gai2
FTY720 has long been shown to induce internalization of S1P 1 R on T cells, abolishing S1P-mediated chemotaxis and thus egress of the cells (4-7). Lack of Gai2 might abrogate FTY720-induced receptor internalization, rendering the cells refractory to FTY720-induced lymphopenia. To address this, the level of S1P 1 R expression was analyzed on lymph node T cells isolated from FTY720-treated and nontreated mice by a polyclonal Ab specific for the N-terminal 49 amino acid residues of mouse S1P 1 R as described (7) . It was found that S1P 1 R expression diminished indiscriminately to background levels in the presence or absence of Gai2 in 16 h after gavage of 1 mg/kg FTY720 (Fig. 2) . Similar receptor modulation in these three groups of T cells was also observed after 44 or 66 h of FTY720 treatment (data not shown).
The result confirms that Gai2 2/2 T cells exit lymph nodes independent of the cell surface S1P 1 R receptor.
Egress of Gai2
2/2 T cells in FTY720-treated mice was not ascribed to altered cell motility Cell motility was tracked by real-time imaging of the popliteal lymph node in WT mice receiving equal numbers of fluorescently labeled T cells prepared from Gai2 2/2 or Gai3 2/2 and WT mice (19) . The average velocities of Gai3 2/2 and WT T cells were comparable in control mice and were not altered significantly after FTY720 treatment (Supplemental Fig. 2A) . Unexpectedly, the velocity of Gai2 2/2 T cells decreased, rather than increased, by ∼20% compared with that of WT or Gai3 2/2 T cells in the distal area of the cortical sinus, irrespective of FTY720 treatment (Supplemental Fig. 2A ), similar to that described with Gai2 2/2 B cells (8) . A decrease in the velocity of Gai2-deficient T cells was also described previously (26) and might be associated with an impaired response to retention chemokines like SDF-1 as shown in our previous study (13) . Superimposed tracking of 20 randomly selected cells of each phenotype over 15 min confirmed similar tracks for Gai3 2/2 and WT T cells but less vigorous Fig. 2B) . The decreased motility superficially contradicted sufficient egress of Gai2 2/2 T cells in FTY720-treated mice.
Gai2
2/2 T cells enter, but WT T cells depart, the cortical sinus in the presence of FTY720
We then tracked T cell behavior around cortical sinusoids of lymphoid nodes, because these structures were identified recently to be sites for T cell egress (8, 9) . We found no significant difference in the distribution of T cells lacking either Gai2 or Gai3 protein inside and outside cortical sinusoids in control mice (Fig. 3A-C) . Enumeration of ∼600 cells inside the sinusoids in 20-30 randomly selected imaging stacks collected from six lymph nodes revealed that average numbers of WT, Gai2
, and Gai3 2/2 T cells were similar in these regions (Fig. 3A-C, 3G) . Likewise, the numbers of Gai2
, and WT T cells within 30 mm of each cortical sinus were comparable (Fig. 3A-C, 3H) (8) (Fig. 3D-G) . In sharp contrast, the number of Gai2 2/2 T cells inside the sinuses remained almost identical to that in control mice (Fig. 3D, 3F, 3G) . Clearly, Gai2 2/2 T cells exit lymph nodes in FTY720-treated animals through the same anatomic structure. Also noticed was a strong bias in the number of Gai2 2/2 T cells (green) in the surrounding area (,30 mm) of sinusoids as delineated by a dotted yellow line in mice receiving Gai2 2/2 T cells and WT or Gai3 2/2 T cells (Fig. 3D, 3F, 3H ; p , 0.001). The ability of Gai2 2/2 T cells to enter the sinus sufficiently, concurrent with a drastic decrease in the entry of WT or Gai3 2/2 T cells, gave rise to a majority of Gai2 2/2 T cells and a scant fraction of WT or Gai3 2/2 T cells inside sinusoids in FTY720-treated mice (Fig. 3D, 3F, 3G; p , 0.001) . These imaging studies demonstrate a similar behavior between WT and Gai3
2/2
T cells and distinct behavior between Gai2
2/2 and Gai3 2/2 or WT cells in the vicinity of the sinus in FTY720-treated mice, in agreement with in vivo flow cytometric analysis (Fig. 1) . 
Increased adhesion of Gai2 2/2 T cells to the sinusoid surface
To identify a potential difference between WT and Gai2 2/2 T cells in their abilities to approach, engage, crawl along, and retract from the cortical sinus in control and FTY720-treated mice, timeseries images of individual cells were enlarged and traced. Representative images are shown in Fig. 4 in which one WT cell (red, white arrow), followed by a Gai2 2/2 cell (green, white arrow), approached and entered a sinusoid by the same exit site in control mice (Fig. 4A ). Another WT cell (yellow arrow) approached, adhered, and then protruded its leading edge into the sinus before entry. Likewise, two WT cells approached and engaged different sinusoids for ∼7 or 3 min, respectively, and established adhesion on the sinus before they successfully crossed the sinusoid wall in control mice (Fig. 4C, Supplemental Video 1) . In sharp contrast, WT cells approached, engaged, and sometimes even extended a process into the sinus but retracted and went away in FTY720-treated mice (Fig. 4B, 4D, arrowhead, Supplemental Videos 2, 3) . Although the drug drastically altered the behavior of WT cells, it appeared to have little impact on Gai2 2/2 T cells. As can be seen in Fig. 1B , a Gai2 2/2 T cell adhered to the sinusoid, polarized, and penetrated into it in the presence of FTY720 (Supplemental Videos 2, 4). We observed only occasionally Gai2 2/2 T cells migrating away from the sinus during the imaging study. In many cases, Gai2 2/2 T cells adhered to a specific site on the sinusoid surface so strongly that they could not be pulled away despite vigorous motion of their pseudopodia for several minutes (Fig.  4D, arrowheads, Supplemental Movies 3, 4) .
Enhanced adhesion of Gai2 2/2 T cells to the sinusoid surface was illustrated further by analyzing 20 randomly selected WT cells and an equal number of Gai2 2/2 cells that were either already adhered to the sinus when the recording started or migrating toward and subsequently engaging the sinus in the same region during a 25-min recording period of time. Among the 20 WT cells traced, 9 of them entered and 8 moved away from the sinus in control mice, indicating a balance between sinus-away and sinus-entry signals under a physiological condition (Fig. 5A ). This probably also held truth for Gai2 2/2 T cells in which 8 cells entered and 5 cells departed, albeit at a reduced rate in either direction (Fig. 5B) . The diminished rate of both sinus-away and sinus-entry movement brought about a greater number of Gai2 2/2 cells remaining on the sinus than WT cells (Fig. 5B versus Fig.  5A ), with 7 Gai2 2/2 cells firmly adherent on the sinus for more than 2 min without displacement, in contrast to only 3 WT cells sticking on the sinus (Fig. 5A, 5B ). The number of Gai2 2/2 cells sticking on the sinus further increased to 14 in the presence of FTY720 (Fig. 5D) . However, an opposite trend was seen in the presence of Gai2, with only one WT cell (fourth cell in Fig. 5C ) adhering to the sinus, and this was the cell that was able to enter the sinus (Fig. 5C) . Remarkably, none of the cells that formed sufficient adhesion on the sinus, as marked in black arrowheads, migrated away, regardless of Gai2 expression, and all of them were able to enter the sinus in the presence or absence of FTY720. The observation argues that the formation of an anchor between T cells and the sinus may be required to "stop" the sinus-away signal and to acquire a polarized cell shape for them squeezing into the sinus. Thus, a failure to establish sufficient interactions between T cells and sinuses robustly increased the number (17) of FIGURE 5 . Lack of Gai2 facilitates adhesion of T cells to the sinusoid surface. A-D, The time spent by individual donor T cells that remained on the outer border of the cortical sinuses and their subsequent movements were compared between control (A, B) and FTY720-treated (C, D) mice. The time in which cells engaged and entered the sinuses is indicated in green, whereas the duration during which cells crawled on the sinus but failed to cross and then moved away is indicated in blue. The red bars indicate the times in which a cell adhered to the same site on the sinus without displacement until the end of imaging; the orange bars are durations during which a cell kept amoeboid migrating on the sinus; arrowheads indicate the cells that adhered to a single point on the sinus for longer than 2 min regardless of whether they crossed the sinus; and "j" indicates cells that never adhered to the sinus for longer than 2 min after they engaged the sinus. The data are representative of three independent experiments. E, T cell migration on the surface of the cortical sinus in the presence or absence of Gai2 in FTY720-treated mice. Superimposed tracks of 20 randomly selected WT or Gai2 2/2 donor T cells were recorded when the cells began engagement of the sinus and ended when the cells left in FTY720-treated recipient mice. The data are representative of images collected from six lymph nodes in each treatment. F-H, Frequencies at which WT, Gai2
donor T cells moved away (F), adhered to (G), or entered (H) the cortical sinus in control and FTY720-treated mice were calculated by manually tracking individual cells in each time-lapse image, with a total of 400 cells in 20 imaging stacks. Adhesion was defined as a cell adhered to a single point on the sinusoid surface without displacement for longer than 2 min. Each dot represents data from a single time-lapse image, and the lines represent the means. The data are collected from six lymph nodes imaged in each treatment. *p , 0.05, **p , 0.01, ***p , 0.001 in the presence or absence of Gai2 or FTY720.
WT T cells departing the sinus, preventing their egress (Fig. 5C ). However, a lack of Gai2 strengthened T cell adhesion to the sinusoid surface, which prevented their migration away and facilitated their transmigration of the sinusoids (Fig. 5D) . A few Gai2
2/2
T cells did not establish adhesion on the sinusoid surface and departed in the presence of FTY720 (Fig. 5D , Supplemental Video 5). A blockade of T cell-sinus interactions by FTY720 was consistent with vigorous movement of the cells over the sinusoid surface, which was reflected by superimposed tracking of 20 randomly selected WT T cells (Fig. 5E) . The unrestricted migratory paths were in sharp contrast to the locally confined migration seen in most Gai2 2/2 T cells. Tracking of 400 cells from 20 samples, except for Gai3
T cells in which 12 samples were analyzed, further corroborated an inverse relationship between sinus-away migration and adhesive responses in both the presence and the absence of FTY720 (Fig. 5F versus Fig. 5G ). The frequency of WT or Gai3 2/2 T cells departing the sinus increased from 39 or 43% in the absence of FTY720 to 85 or 86% in the presence of the drug (Fig. 5F ), with only a few cells remaining on the sinus (Fig. 5G) , conferring very few chances for the cells to exit (Fig. 5H) . On the contrary, the drug greatly enhanced the adhesion of Gai2 2/2 T cells on the sinus (Fig. 5G ), concomitant with a sharp decrease in the number of cells migrating away (Fig. 5F ). The enhanced adhesion was in a good agreement with their reduced motility on or around the sinus (Fig. 5E ). Despite their ability to enter the sinus, Gai2
T cells transmigrated the sinusoids at a significantly low level in the presence of FTY720 compared with that in the absence of FTY720 (Fig. 5H) , presumably owing to S1P 1 R receptor internalization. The diminished transmigration might be responsible for an initial decline in the number of circulating Gai2 2/2 T cells (,4 h) after FTY720 treatment (Fig. 1) . In support of a role for S1P-induced chemotaxis in T cell egress, Gai2-and Gai3-deficient T cells entered the sinus at an efficiency slightly lower than that of WT cells in the control mice (Fig. 5H, p , 0 .01 or 0.05, respectively), which is consistent with the slightly reduced chemotaxis induced by S1P in these cells described previously (14) . The reduced entry of Gai2 2/2 T cells into the sinus might be compensated eventually by an increasing number of cells adherent on the sinus, resulting in the normalization of circulating Gai2 2/2 T cells in 8 h after FTY720 treatment (Fig. 1) . The results suggest that both receptor internalization and enhanced sinus-away migration contribute to FTY720-induced sequestration of T cells in the lymphoid tissue.
Discussion
The investigation reveals, for the first time, to our knowledge, the possible involvement of T cell adhesion on the sinus for regulating egress of lymphocytes, in a good agreement with a multistep model of T cell egress that requires S1P 1 R-independent probing of the sinus before S1P-guided entry (27) . The role of T cell adhesion to the sinus in intravasation may be similar to that in extravasation. During the process of extravasation, leukocytes adhere to endothelial cells or extracellular matrix, a process by which they stop a shear force and acquire a polarized cell shape enabling them to squeeze into the tissues through a vessel wall. Sticking of T cells on the sinusoid surface appeared to "stop" the tissue-retention or sinus-away signal in favor of T cells transmigrating across the sinus during T cell egress. The importance of halting the sinusaway signal for T cell egress is underscored by the observation that none of the cells that had formed firm adhesion on the sinus moved away in the presence or absence of FTY720. On the basis of these observations and published data, we propose a model for T cell egress as depicted in Supplemental Fig. 3 . T cells crawl along chemokine-decorated fiber paths generated by fibroblastic reticular cells in the T cell zone, approach, and engage the sinus (28), after which T cells adhere to the sinus that prohibits the cells from migrating away. The adhesion is followed presumably by deadhesion and entry of the cells into the sinus after the cue of S1P. This process is likely to take place quickly in most of cells under physiological conditions and thus may not be captured readily by imaging studies. FTY720 impairs the adhesion or accelerates deadhesion, permitting relatively unrestricted migration of the cells along or away from the sinus, as reflected by vigorous movements of WT cells on the sinusoid surface and frequent retraction to the parenchyma even after they protrude their leading edges into the sinus. In the absence of Gai2, FTY720 treatment strengthens the adhesion that stops the sinus-away signal and promotes T cells entry to the sinus with or without the S1P cue (Supplemental Fig. 3, lower panel) , although the underlying mechanism remains unknown. Ligation of S1P 1 R has been shown to activate integrin-mediated firm arrest in high endothelial venules (29) . The adhesion molecules involved in this intravasation are not known at present, which are presumably different from those adhesion molecules and selectins such as a L b 2 (LFA-1 or CD11a/CD18), a 4 b 1 (VLA-4), and L-selectin for diapedesis or S1P 1 R-induced tissue retention in the skin (30) because sticking of Gai2 2/2 T cells occurs only on the surface of the sinus in the presence or absence of FTY720. Moreover, injection of neutralizing Abs against integrins such as a L , a 4 , or b 2 did not reveal any role for these integrins in lymphocyte egress from secondary lymph organs (7, 31) . Gai2-deficient T cells may provide us with a unique opportunity to unravel the nature of the adhesion molecules involved in T cell egress because of their extended adhesion on the sinus. S1P 1 R has been shown to exclusively couple with PTXsensitive heterotrimeric Gai/o proteins (10) . T cells express only Gai2 and Gai3, and no Gai1 or Gao is expressed to compensate for a loss of either Gai protein in Gai2-and Gai3-deficient mice as analyzed by RT-PCR (data not shown) (32) . These two Gai proteins were thought to be redundant in coupling to S1P 1 R, because Gai2-and Gai3-deficient T cells both displayed similar chemotactic responses to S1P, albeit to a slightly lower degree compared with that of WT cells (14) . T cell egress and emigration of thymocytes were normal in these two strains of mice (16) . Binding of FTY720 to S1P 1 R also induced S1P 1 R internalization on these three groups of cells but sequestered WT and Gai3
2/2
T cells not Gai2
2/2 T cells. The importance of Gai2 in FTY720-stimulated sequestration was implicated strongly by restoring the response in Gai2-deficient T cells after ectopic Gai2 expression. Mullershausen et al. (33) recently showed long persistent signaling induced by phosphorylated FTY720 after S1P 1 R internalization in Chinese hamster ovary cells expressing S1P 1 R or primary HUVECs. Persistent activation of Gai2 proteins by internalized S1P 1 R may play a critical role in the abrogation of T cell and sinusoid interaction, probably in part through the inhibition of cAMP production, in light of the importance of cAMP in cell-cell adhesion and the well-documented cAMP inhibitory activity of Gai (34) , which is currently under investigation.
Our study also provides compelling evidence demonstrating that FTY720 modulation of T cell egress is attributed directly to its action on T cells rather than endothelial cells and that FTY720 does not close the lymphatic endothelial "stromal portal," if it exists (35) . Hence, FTY720 could not block egress of Gai2 2/2 T cells, irrespective of whether the cells were adoptively transferred into WT or Gai2 2/2 mice. Its action is also unlikely via other S1P receptors, other than the S1P 1 R, because SEW2871 that is specific for the S1P 1 R cannot inhibit egress of Gai2 2/2 T cells either.
Moreover, restoration of FTY720-mediated responses in Gai2
T cells after the transfection of Gai2, but not Gai3, into the cells corroborated that failure of FTY720 to sequester Gai2 2/2 T cells in the secondary lymphoid tissues did not result from a developmental defect in the cells (Fig. 1D) . Consistent with this was our early study showing that thymic emigration of T cells was normal in Gai2 2/2 mice despite an increase in the number of CD4 + and CD8 + cells in the thymus (25) . The latter was attributed to an accelerated transition from double-positive to single-positive thymocytes (25) . There was also no significant alteration in T cell distribution in Gai2-and Gai3-deficient mice at adulthood, despite a defect in newborn mice in the absence of either Gai2 or Gai3 (16) .
The current investigation demonstrates that FTY720 blocks egress of T cells by abrogation of T cell and sinusoid interactions in addition to the induction of S1P 1 R internalization. These novel mechanistic insights into T cell egress can potentially serve as a basis for identifying new therapeutic targets.
